ALOBRESIB
UNII 3QBL0BLP3D

Substance Identification & Data

This profile provides standardized clinical and technical data for Alobresib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3QBL0BLP3D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1637771-14-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3QBL0BLP3D

CAS Registry Number

1637771-14-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ALOBRESIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C26H23N5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CMSUJGUHYXQSOK-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C126640

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

86281210

Unique identification number in the NCBI database of chemical substances.

INN ID

10633

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(cc(c2c1[nH]c(n2)C3CC3)C(c4ncccc4)(c5ccccn5)O)-c6c(onc6C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Alobresib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.